Evidence map›Paper›PMID 42266120›Full record

ArticleAnnals of coloproctology2026

Radiofrequency for the treatment of pilonidal disease: results of a French prospective pilot study.

Nadia Fathallah, Amine Antonin Alam, Maria Skoufou, Marie Lazareth, Lucas Spindler, Manuel Aubert, Eric Safa Far, Elise Pommaret, Amélie Barré, Mathilde Wisniewski and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Annals of coloproctology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05855733 (Radiofrequency Treatment for Pilonidal Disease), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05855733 naunknown statusnot on this map

Radiofrequency Treatment for Pilonidal Disease : Clinical Investigation on Safety of Use, Efficacy and Patient Satisfaction at 6 Months

TypeinterventionalSponsorFondation Hôpital Saint-JosephRan2023 to 2024Enrolled50ConditionsInfected Pilonidal SinusArmsradiofrequency treatment
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nadia FathallahDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Amine Antonin AlamDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Maria SkoufouDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Marie LazarethDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Lucas SpindlerDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Manuel AubertDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Eric Safa FarDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Elise PommaretDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Amélie BarréDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Mathilde WisniewskiDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Sinon KurtDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Dior MaroneDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Vincent de ParadesDepartment of Medical and Surgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.

Funding

F Care Systems
6 · The paper itself

Abstract

purposeMinimally invasive techniques are increasingly applied in the management of pilonidal disease. While laser therapy is well established, radiofrequency (RF) represents a newer alternative with theoretical advantages. However, no prospective data have yet been published on its use. This study aimed to assess the safety, efficacy, and patient satisfaction associated with RF treatment for infected pilonidal sinus.

methodsWe conducted a prospective, single-center pilot study including consecutive patients treated with RF between March and December 2023. The procedure was performed under spinal or general anesthesia in an outpatient setting using a radial RF probe (25 W, 4 MHz) following mechanical debridement. Patients were followed up at 15 days and at 1, 3, and 6 months. The primary endpoint was safety; secondary endpoints included healing rate, predictors of failure, postoperative pain, return to activities, and patient satisfaction.

resultsForty-four patients were enrolled (median age, 25.5 years; 31 men, 70.5%), of whom 38.6% had undergone previous surgery. The median operative time was 12 minutes. No major complications occurred, and minor early events were reported in 6.8% of cases. Complete healing at 6 months was achieved in 77.3% of patients. Failure and recurrence rates were 13.6% and 9.1%, respectively. A history of prior surgery significantly increased the risk of failure (odds ratio, 0.2; P=0.005). The median peak pain score was 2 out of 10, with a median duration of 2 days. Overall, 33 patients (75.0%) were very satisfied, and 40 (90.9%) stated they would undergo the procedure again or recommend it to others.

conclusionRF appears to be a safe, minimally invasive outpatient treatment option for pilonidal disease, demonstrating promising efficacy, minimal postoperative pain, and high patient satisfaction. Trial registration: ClinicalTrials.gov identifier: NCT05855733.

Indexed as

Minimally invasive surgical proceduresOutpatient surgeryPilonidal sinusProspective studiesRadiofrequency therapy

Identifiers

PMID42266120
PMCPMC13254772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.